Volume 13, Issue 1 (Scientific Journal of Hamadan University of Medical Sciences-Spring 2006)                   Avicenna J Clin Med 2006, 13(1): 43-47 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bazzazi N, Barazandeh B. Evaluating Efficacy of Nasolacrimal Duct Probing with Adjunctive Mitomycin C in the Treatment of Adult Epiphora. Avicenna J Clin Med. 2006; 13 (1) :43-47
URL: http://sjh.umsha.ac.ir/article-1-503-en.html
1- , Nooshin_bazzazi@yahoo.com
Abstract:   (3331 Views)

Introduction & Objective: Nasolacrimal duct obstruction (NLDO) is the most common cause of epiphora in adults. Our purpose was the evaluation of efficacy and complications of NLD probing with adjunctive MMC in the treatment of partial NLDO in adults.

Materials & methods: This clinical trial study without control group (quazi experimental) was carried out in adult patients with symptom of epiphora. 40 patients (46 eyes) with partial obstruction of Nasolacrimal duct participated in this study. 6 patients had bilateral and 34 patients had unilateral epiphora. Each patient was followed for at least 6 months and visited 2 weeks, 1 month, 3 months and 6 months after the probing.

Results: After 6 months follow up in 20 eyes (43.6%) Nasolacrimal duct was patent (confirmed with irrigation( and 21 patients (52.5%) were symptomatically satisfied. After 6 months follow up no complication was observed.

Conclusion: This study showed that probing and irrigation with mitomycin C (0.2 mg/ml) was a method with relatively high success rate and could be an appropriate alternative option for relieving partial obstruction of the Nasolacrimal duct obstruction. Its advantages include simplicity, low morbidity, operable without general anesthesia and with simple instruments.

Full-Text [PDF 217 kb]   (1346 Downloads)    
Type of Study: Original | Subject: Other Clinical Specialties

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Avicenna Journal of Clinical Medicine

Designed & Developed by : Yektaweb